Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Falardeau

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Seminars in Oncology|December 12, 2001
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trialsP Falardeau, P Champagne, P Poyet, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1990
Prostanoids and aldosterone-induced mild experimental hypertension in ratsR T Hui, J H Grose, M Lebel, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Contrasting dopaminergic patterns in two forms of genetic hypertensionO Kuchel, K Racz, W Debinski, et al.
The Journal of Clinical Investigation|November 1, 1981
Estimated rate of prostacyclin secretion into the circulation of normal manG A FitzGerald, A R Brash, P Falardeau, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1991
Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the ratR Hui, M Robillard, J H Grose, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1986
Effect of indomethacin treatment on prostaglandin excretion and tissue phospholipid fatty acid composition in rats bearing mammotropic pituitary tumor, MtT-F4Y S Huang, P Falardeau, A Martineau, et al.
European Journal of Pharmacology|May 20, 1988
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeysP Falardeau, S Bouchard, P J Bédard, et al.
Burns : Journal of the International Society for Burn Injuries|August 5, 2000
Veno-venous continuous renal replacement therapy for burned patients with acute renal failureR Tremblay, J Ethier, S Quérin, et al.
Endocrinology|August 1, 1985
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity formS R George, M Watanabe, T Di Paolo, et al.
Advances in Neurology|January 1, 1993
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeysP J Bédard, B Gomez-Mancilla, P Blanchette, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Seminars in Oncology|December 12, 2001
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trialsP Falardeau, P Champagne, P Poyet, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1990
Prostanoids and aldosterone-induced mild experimental hypertension in ratsR T Hui, J H Grose, M Lebel, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Contrasting dopaminergic patterns in two forms of genetic hypertensionO Kuchel, K Racz, W Debinski, et al.
The Journal of Clinical Investigation|November 1, 1981
Estimated rate of prostacyclin secretion into the circulation of normal manG A FitzGerald, A R Brash, P Falardeau, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1991
Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the ratR Hui, M Robillard, J H Grose, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1986
Effect of indomethacin treatment on prostaglandin excretion and tissue phospholipid fatty acid composition in rats bearing mammotropic pituitary tumor, MtT-F4Y S Huang, P Falardeau, A Martineau, et al.
European Journal of Pharmacology|May 20, 1988
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeysP Falardeau, S Bouchard, P J Bédard, et al.
Burns : Journal of the International Society for Burn Injuries|August 5, 2000
Veno-venous continuous renal replacement therapy for burned patients with acute renal failureR Tremblay, J Ethier, S Quérin, et al.
Endocrinology|August 1, 1985
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity formS R George, M Watanabe, T Di Paolo, et al.
Advances in Neurology|January 1, 1993
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeysP J Bédard, B Gomez-Mancilla, P Blanchette, et al.
Pageof 8